Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Patterson Cos. (PDCO) a Great Value Stock Right Now?

Anthem

Labcorp Holdings Inc

Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.

3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility

Patterson (PDCO) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Why Patterson (PDCO) Could Be Positioned for a Surge

Quest Diagnostics

Sprouts Farmers Markets

Sleep Number

T-Mobile US

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

5 Stocks With Relative Price Strength to Enhance Your Returns

Cerner

Once the pandemic-led crisis eases, these MedTech stocks will likely flourish on the back of number of positive developments.

3 Cheap MedTech Stocks Set to Gain Once Coronavirus Crisis Ebbs

As of late, it has definitely been a great time to be an investor in Patterson Companies.

Patterson Companies' Shares March Higher, Can It Continue?

Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Earnings Estimates Moving Higher for Patterson Cos. (PDCO): Time to Buy?

Hologic

Here are some MedTech stocks which might be a solid investment option post the coronavirus blues.

4 Cheap MedTech Stocks Poised to Beat Industry Post-Pandemic

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q4 2020 Results - Earnings Call Transcript

Patterson Companies' (PDCO) fiscal fourth-quarter results reflect dismal performance by Dental and Animal Health segments.

Patterson Companies (PDCO) Q4 Earnings Top Estimates, Up Y/Y

Patterson Cos. Inc. PDCO, +2.89% said Wednesday it swung to a loss of $608.6 million, or $6.44 a share, in its fiscal fourth quarter to April 25, after earnings of $27.9 million, or 30 cents a share, in the year-earlier period.

Patterson companies swings to loss as COVID-19 disrupts dental market

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal year 2020 and fourth quarter ended April 25, 2020. “The strategies we executed during fiscal 2020 produced accelerating performance through the first 11 months, enabling us to exceed our goals for the year despite the impact of COVID-19, resulting in full fiscal 2020 adjusted earnings growth of 10.7 percent,” said Mark Walchirk, President and CEO of Patterson Companies. “Ou

Patterson Companies Reports Fiscal 2020 Fourth-Quarter and Year-End Operating Results

AmerisourceBergen

Align Technology

Becton, Dickinson and Co.

Cardinal Health

Cooper Companies

Henry Schein

McKesson

DENTSPLY SIRONA

Near-Term Outlook Bleak for Medical Dental Supplies Industry

AECOM

Allegheny Technologies

Bill.com

BorgWarner

China Unicom

Consolidated Communications Holdings

Everbridge

Focus Financial Partners

ManTech

NetEase

Pool

Pure Storage

Dr. Reddy's Labs

United Natural Foods

Veoneer Inc

Werner Enterprises

Workiva

Woodward

To hear some tell it, bigger is always better on Wall Street.

19 of the Best Stocks You've Never Heard Of

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Earnings Preview: Patterson Cos. (PDCO) Q4 Earnings Expected to Decline

AbbVie

Bunge Global SA

Chevron

DXC Technology

Nu Skin Enterprises

Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum.

8 Safe High-Yield Dividend Stocks Offering 5% or More

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Down 33.5% Since Last Earnings Report: Can It Rebound?

Amkor Technology

Donnelley Financial Solutions

MarineMax

US Foods Holding

We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.

Pick These 5 Value Stocks With Alluring EV/EBITDA Ratios

Campbell Soup

Duke Energy

MDU Resources Group

Procter & Gamble

The coronavirus pandemic is spooking investors, making them hunt for safe stocks to invest. Here are six defensive stocks that provide stable dividends.

6 Stocks to Buy Despite Coronavirus-Driven Market Volatility

Patterson Companies (PDCO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Is Patterson Companies (PDCO) Stock a Solid Choice Right Now?

Patterson Companies (PDCO) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

Why Patterson Companies (PDCO) Could Be a Top Value Stock Pick

PDCO vs. BDX: Which Stock Is the Better Value Option?

PDCO or BDX: Which Is the Better Value Stock Right Now?

Target

Costco

General Motors

JD.com

General Motors, Patterson Companies, JD.com, Costco and Target were our top stock trades for Tuesday. That said, let's look at the charts.

5 Top Stock Trades for Tuesday: COST, TGT, JD, GM & PDCO

Patterson Companies (PDCO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Patterson Companies (PDCO) Catches Eye: Stock Jumps 5.9%

Patterson Companies, Inc. (PDCO) CEO Mark Walchirk on Q3 2020 Results - Earnings Call Transcript

News for Patterson Companies Stock (PDCO)